Sg Americas Securities, LLC Akebia Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 71,965 shares of AKBA stock, worth $135,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,965

Previous 33,144 117.13%

Holding current value

$135,294

Previous $34,000 179.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$0.94 - $1.55 $36,491 - $60,172	38,821 Added 117.13%	71,965 $95,000
Q2 2024 Jul 12, 2024	BUY	$0.86 - $1.63 $28,503 - $54,024	33,144 New	33,144 $34,000
Q1 2022 Apr 29, 2022	SELL	$0.72 - $2.93 $31,086 - $126,505	-43,176 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.26 - $3.34 $153,869 - $227,400	-68,084 Reduced 61.19%	43,176 $98,000
Q3 2021 Nov 01, 2021	BUY	$2.35 - $3.88 $231,294 - $381,881	98,423 Added 766.71%	111,260 $320,000
Q2 2021 Aug 12, 2021	SELL	$2.83 - $4.2 $51,166 - $75,936	-18,080 Reduced 58.48%	12,837 $49,000
Q1 2021 May 13, 2021	BUY	$2.92 - $5.06 $36,269 - $62,850	12,421 Added 67.16%	30,917 $105,000
Q4 2020 Feb 04, 2021	SELL	$2.22 - $3.78 $475,892 - $810,303	-214,366 Reduced 92.06%	18,496 $52,000
Q3 2020 Nov 09, 2020	BUY	$2.39 - $13.08 $427,133 - $2.34 Million	178,717 Added 330.07%	232,862 $584,000
Q2 2020 Jul 20, 2020	BUY	$6.67 - $13.58 $128,564 - $261,754	19,275 Added 55.28%	54,145 $735,000
Q1 2020 Apr 30, 2020	BUY	$4.1 - $10.24 $39,909 - $99,676	9,734 Added 38.73%	34,870 $264,000
Q4 2019 Jan 28, 2020	BUY	$3.16 - $6.73 $33,729 - $71,836	10,674 Added 73.81%	25,136 $159,000
Q3 2019 Nov 04, 2019	BUY	$3.55 - $5.4 $51,340 - $78,094	14,462 New	14,462 $57,000
Q2 2019 Jul 29, 2019	SELL	$4.1 - $8.05 $109,867 - $215,715	-26,797 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$5.41 - $8.73 $282,548 - $455,941	-52,227 Reduced 66.09%	26,797 $219,000
Q4 2018 Feb 01, 2019	SELL	$5.39 - $9.15 $3,260 - $5,535	-605 Reduced 0.76%	79,024 $437,000
Q3 2018 Nov 06, 2018	BUY	$7.44 - $10.65 $592,439 - $848,048	79,629 New	79,629 $703,000
Q4 2017 Jan 24, 2018	SELL	$14.24 - $19.59 $123,176 - $169,453	-8,650 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$13.06 - $19.67 $112,969 - $170,145	8,650	8,650 $170,000

Others Institutions Holding AKBA

# of Institutions

121

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $346M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Akebia Therapeutics, Inc. Transaction History